Kevin W. Mayo

Kevin W. Mayo, Ph.D. is a distinguished professional with extensive experience in market access, health economics, and strategic development within the biotechnology and pharmaceutical industries. Currently serving as Senior Vice President at Rapid Commercialization Partners and Vice President of Strategic Development at AGIL f(x), Kevin also holds a foundational role as Managing Partner and Founder of Value Genome LLC. Previously, impactful contributions were made as Senior Director at Jazz Pharmaceuticals and Director of Value Strategy and Evidence at AstraZeneca. Kevin's educational background includes a Ph.D. in Pharmaceutical Marketing & Administration and a Doctor of Law in Health Law. Noteworthy achievements include developing market access strategies for Alnylam's ONPATTRO and establishing market access functions at PTC Therapeutics.